Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-Dotatate Peptide Receptor Radionuclide Therapy: the MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
JOURNAL OF NUCLEAR MEDICINE（2024）
Key words
neuroendocrine tumor,mesenteric mass,objective response,Lu-177-DOTATATE,PRRT
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined